Ampio Pharmaceuticals chief scientific officer to retire
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Ampio Pharmaceuticals Inc. said David Bar-Or will retire as chief scientific officer, effective Sept. 30.
Bar-Or will remain on the Englewood, Colo.-based biopharmaceutical company's board.
He said he plans to do some projects at the Trauma Research Center where he serves as research director for eight medical institutions.
